Lupin receives US FDA approval for generic rifadin capsules
Is indicated for the treatment of all forms of tuberculosis
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Category
Market
Expansion of product offerings with focus on cancer therapeutics drives M&A activity
India market sees no deals in August ‘13
Piramal Healthcare to invest $11 million at its UK facility
Work on the new suite, which will house formulation, packaging coating and tableting equipment, will commence at the end of 2013
PSM India organises workshops on pharmacovigilance
Stakeholders across the spectrum deliberated on the current state of pharmacovigilance and ways to make the system stronger.…
National Forum on Tuberculosis holds first meeting in New Delhi
Discusses the rise and challenges of drug-resistant TB in India
OPPI seminar debates healthcare access in India
The event saw the presence of distinguished professionals, acclaimed experts and scientists from the Indian healthcare industry…
UK seeks to create healthy business environment with India
13 British pharma, life sciences and research organisations on a business visit to India
Rising above Neglect
In January last year, 13 pharmaceutical companies alongwith the US, the UK and the UAE governments; Bill & Melinda Gates…
Jubilant Biosys files IND with US-based Endo Pharmaceuticals
IND relates to a novel molecule targetting prostate cancer